ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      96,207.48
      -1.03%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. IN8bio Inc (INAB) Quote

      IN8bio Inc

      IN8bio Inc (INAB)

      NASDAQ
      0.2488
      0.0084
      (3.49%)
      Closed December 22 4:00PM
      Delayed by 15 minutes
      0.25
      0.0012
      (0.48%)
      After Hours: 7:57PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.25
      Bid
      0.231
      Ask
      0.2849
      Volume
      1,329,795
      0.2303 Day's Range 0.2552
      0.217 52 Week Range 1.93
      Market Cap
      18.121M
      Previous Close
      0.2404
      Open
      0.231
      Last Trade
      500
      @
      0.25
      (formt)
      Last Trade Time
      Financial Volume
      $ 329,424
      VWAP
      0.247726
      Average Volume (3m)
      1,259,479
      Shares Outstanding
      72,483,253
      Dividend Yield
      -
      PE Ratio
      -0.58
      Earnings Per Share (EPS)
      -0.41
      Revenue
      -
      Net Profit
      -30.01M

      About IN8bio Inc

      IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.in8bio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.24. Over the last year, IN8bio shares have traded in a share price range of $ 0.217 to $ 1.93.

      IN8bio currently has 72,483,253 shares outstanding. The market capitalization of IN8bio is $17.42 million. IN8bio has a price to earnings ratio (PE ratio) of -0.58.

      Ask ADVFN Intelligence (AI)

      INAB Latest News

      More News

      Form 8-K - Current report

      December 10 2024
      Edgar (US Regulatory)

      IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

      INB-100 continues to demonstrate durable complete remissions (CR) with no relapses observed in any acute myeloid leukemia (AML) patients including those with high-risk disease after a median...

      December 10 2024
      GlobeNewswire Inc.

      IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference

      NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...

      December 02 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      November 25 2024
      Edgar (US Regulatory)

      IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting

      50% of patients who received repeated doses (n=10) remained alive and in remission beyond the expected median overall survival (OS) from standard-of-care Stupp regimen while none of the patients...

      November 25 2024
      GlobeNewswire Inc.

      Form EFFECT - Notice of Effectiveness

      November 13 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      November 12 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

      Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...

      November 12 2024
      GlobeNewswire Inc.

      IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

      Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...

      November 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0422-14.44216290210.29220.31640.244131080.26835529CS
      4-0.07-21.8750.320.410.246892000.32446998CS
      12-0.035-12.28070175440.2850.55660.21712594790.37858986CS
      26-0.74-74.74747474750.990.9990.2177213650.41209241CS
      52-1.25-83.33333333331.51.930.2175447010.67137332CS
      156-5.66-95.76988155675.916.790.2176856412.0582461CS
      260-9.75-97.51010.3190.2176116562.1137244CS

      INAB - Frequently Asked Questions (FAQ)

      What is the current IN8bio share price?
      The current share price of IN8bio is $ 0.25
      How many IN8bio shares are in issue?
      IN8bio has 72,483,253 shares in issue
      What is the market cap of IN8bio?
      The market capitalisation of IN8bio is USD 17.42M
      What is the 1 year trading range for IN8bio share price?
      IN8bio has traded in the range of $ 0.217 to $ 1.93 during the past year
      What is the PE ratio of IN8bio?
      The price to earnings ratio of IN8bio is -0.58
      What is the reporting currency for IN8bio?
      IN8bio reports financial results in USD
      What is the latest annual profit for IN8bio?
      The latest annual profit of IN8bio is USD -30.01M
      What is the registered address of IN8bio?
      The registered address for IN8bio is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the IN8bio website address?
      The website address for IN8bio is www.in8bio.com
      Which industry sector does IN8bio operate in?
      IN8bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MYSZMy Size Inc
      $ 4.2001
      (211.12%)
      		121.03M
      NVNINVNI Group Ltd
      $ 8.26
      (209.36%)
      		78.06M
      TPICTPI Composites Inc
      $ 2.45
      (100.82%)
      		34M
      ICGIntchains Group Ltd
      $ 8.77
      (88.60%)
      		527.94k
      HSDTHelius Medical Technologies Inc
      $ 0.884851
      (84.34%)
      		121.95M
      CYNCYNGN Inc
      $ 0.4603
      (-71.41%)
      		27.5M
      MTEMMolecular Templates Inc
      $ 0.1502
      (-57.09%)
      		8.63M
      PRFXPainReform Ltd
      $ 5.15
      (-53.85%)
      		2.84M
      GALTGalectin Therapeutics Inc
      $ 1.03
      (-48.50%)
      		8.58M
      BCABBioAtla Inc
      $ 0.6923
      (-41.82%)
      		5.96M
      EDBLEdible Garden AG Inc
      $ 0.24
      (65.06%)
      		354.33M
      NVDANVIDIA Corporation
      $ 134.70
      (3.08%)
      		310.19M
      APTOAptose Biosciences Inc
      $ 0.28
      (64.51%)
      		306.25M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.606999
      (6.49%)
      		293.22M
      PLTRPalantir Technologies Inc
      $ 80.55
      (8.54%)
      		281.23M

      INAB Discussion

      View Posts
      glenn1919 glenn1919 2 months ago
      INAB....................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 3 months ago
      IN8bio Announces Pricing of $12.4 Million Private Placement
      👍️0
      BurgerKing82 BurgerKing82 4 months ago
      Hello
      👍️0
      glenn1919 glenn1919 4 months ago
      INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      TheFinalCD TheFinalCD 4 months ago
      https://x.com/MSollender/status/1831422943987167269
      👍️0
      Monksdream Monksdream 4 months ago
      INAB new 52 week low
      👍️0
      glenn1919 glenn1919 6 months ago
      INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 7 months ago
      INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
      &p=W&b=5&g=0&id=p86431144783
      👍️0
      Tyrus603 Tyrus603 8 months ago
      Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
      👍️0
      Laster Laster 8 months ago
      Sold my shares this morning that I bought last night for small loss.
      Volume not great. No PM movement (yet).
      Who knows. It may surprise and take off at 9:30 open.
      If it does, then congrats to y’all.
      👍️0
      Invest-in-America Invest-in-America 8 months ago
      INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

      BOTTOM LINE??? GO-GO-GO-INAB!!!!
      👍️0
      glenn1919 glenn1919 9 months ago
      INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      INAB under $2
      👍️0
      murocman murocman 1 year ago
      Surprised how much this has tanked in light of stellar data?

      Murocman
      👍️0
      murocman murocman 1 year ago
      Outstanding data and financing in place to boot!

      Should move up!

      Murocman
      👍️0
      Awl416 Awl416 1 year ago
      IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
      👍️0
      Monksdream Monksdream 1 year ago
      INAB under $2
      👍️0
      Monksdream Monksdream 1 year ago
      INAB new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      INAB new 52 week low
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      like this
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      like this
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      looks good
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      strong chart
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      reaDY
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      reaDY
      👍️0
      Mr Wick Mr Wick 2 years ago
      New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
      Fingers crossed.
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      MrMocha MrMocha 2 years ago
      I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
      👍️ 1
      Mr Wick Mr Wick 2 years ago
      New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
      Looking forward to a buyout.
      👍️ 1
      The Night Stalker The Night Stalker 2 years ago
      right on
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      strong as hell
      👍️0
      Trons Trons 2 years ago
      Headed to $20 on cancer developments
      👍️0
      Jess070283 Jess070283 2 years ago
      Uh oh Shorts I’m trouble….
      👍️0
      trendzone trendzone 2 years ago
      Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
      👍️0
      Jess070283 Jess070283 2 years ago
      Loading this dip for the rip…
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
      HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
      👍️0
      subslover subslover 2 years ago
      Love your scanner! :)
      👍️0
      2020Benzo 2020Benzo 2 years ago
      Did they just post same Orphan Drug news twice in a row it’s sane PR !
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      sub $2
      👍️0
      surf1944 surf1944 2 years ago
      https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

      https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

      https://www.barchart.com/stocks/quotes/inab/opinion

      Back down to $1
      👍️0
      ringo1 ringo1 2 years ago
      Time to take some profits
      👍️0
      Hercules1 Hercules1 2 years ago
      It hit $3.95.

      $4 break is coming.


      $5 quite possible today.
      👍️0
      Hercules1 Hercules1 2 years ago
      Total beast.

      Next stop $4.

      And then $5.
      👍️0
      Awl416 Awl416 2 years ago
      Impressive day
      👍️0
      Jess070283 Jess070283 2 years ago
      What a beast!
      👍️0

      Your Recent History

      NASDAQ
      INAB
      IN8bio
      LSE
      0GJ1
      Mag Interactive Ab (publ)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads